Transpek Industry (TRANSPEK)₹1,293+2.29%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Transpek Industry reported sales of ₹150 Cr, down 2.1% from Jun 2025, and net profit of ₹8.92 Cr, down 42.7% year on year. For the year to Mar 2026, sales were ₹619 Cr and net profit ₹45.93 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121 | 148 | 148 | 151 | 162 | 169 | 165 | 154 | 160 | 158 | 148 | 150 |
| Expenses | 108 | 121 | 130 | 136 | 140 | 146 | 133 | 130 | 134 | 134 | 131 | 131 |
| Operating Profit | 13.32 | 27.60 | 18.72 | 15.99 | 22.45 | 23.88 | 32.12 | 24.00 | 26.60 | 24.86 | 17.69 | 20.08 |
| OPM % | 11.1% | 18.7% | 12.7% | 10.6% | 13.9% | 14.1% | 19.5% | 15.6% | 16.7% | 15.8% | 12.0% | 13.4% |
| Other Income | 4.08 | 4.64 | 4.80 | 11.00 | 5.10 | 4.90 | 7.76 | 11.69 | 5.04 | 3.55 | 4.28 | 4.01 |
| Interest | 3.05 | 3.70 | 3.50 | 3.02 | 2.83 | 3.13 | 2.80 | 2.47 | 2.42 | 1.68 | 1.53 | 1.53 |
| Depreciation | 8.84 | 8.65 | 11.34 | 12.31 | 12.88 | 12.14 | 12.65 | 12.31 | 12.35 | 12.35 | 11.65 | 10.85 |
| Profit before tax | 5.57 | 19.98 | 8.75 | 11.69 | 11.91 | 13.59 | 24.54 | 20.94 | 16.98 | 14.48 | 8.85 | 11.79 |
| Tax % | 46.2% | 29.5% | 35.5% | 20.3% | 19.7% | 21.6% | 21.5% | 25.6% | 25.5% | 25.0% | 25.5% | 24.3% |
| Net Profit | 2.98 | 14.06 | 5.63 | 9.28 | 9.54 | 10.63 | 19.23 | 15.56 | 12.63 | 10.84 | 6.57 | 8.92 |
| EPS (Rs) | 5.33 | 25.11 | 10.06 | 16.58 | 17.03 | 19.01 | 34.33 | 27.78 | 22.53 | 19.36 | 11.73 | 15.94 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 283 | 316 | 360 | 592 | 564 | 337 | 596 | 824 | 578 | 648 | 619 | 616 |
| Expenses | 236 | 263 | 314 | 479 | 447 | 292 | 500 | 676 | 497 | 548 | 528 | 529 |
| Operating Profit | 47.85 | 52.88 | 46.90 | 117 | 118 | 46.85 | 99.75 | 151 | 81.79 | 103 | 92.79 | 89.23 |
| OPM % | 17.1% | 17.0% | 13.0% | 20.1% | 21.1% | 14.0% | 17.1% | 18.1% | 14.1% | 16.0% | 15.1% | 14.5% |
| Other Income | 2.01 | 7.02 | 10.01 | 18.03 | 17.03 | 17.03 | 24.06 | 14.03 | 25.04 | 20.06 | 24.06 | 16.88 |
| Interest | 11.05 | 9.04 | 12.04 | 19.06 | 16.05 | 10.05 | 11.05 | 19.06 | 14.06 | 12.04 | 8.03 | 7.16 |
| Depreciation | 8.01 | 9.01 | 9.99 | 13.99 | 26.01 | 29.02 | 29.99 | 33.02 | 38.03 | 50.04 | 49.03 | 47.20 |
| Profit before tax | 32.06 | 42.03 | 35.04 | 101 | 94.15 | 26.03 | 84.16 | 113 | 56.09 | 62.04 | 61.09 | 52.10 |
| Tax % | 33.0% | 29.0% | 25.0% | 35.0% | 22.0% | 9.0% | 22.0% | 26.0% | 31.0% | 21.0% | 25.0% | — |
| Exceptional items | −0.92 | −0.46 | −0.02 | −0.03 | −0.41 | 0.81 | −3.32 | −1.97 | 0.23 | −6.26 | 0.00 | — |
| Net Profit | 20.99 | 29.99 | 25.98 | 65.91 | 72.94 | 22.97 | 64.91 | 82.87 | 38.96 | 48.95 | 45.93 | 38.96 |
| EPS (Rs) | 36.09 | 53.48 | 47.08 | 117.25 | 130.18 | 41.57 | 116.73 | 149.00 | 68.74 | 86.92 | 81.41 | 69.56 |
| Dividend payout % | 20.9% | 17.0% | 19.0% | 17.0% | 10.0% | 17.9% | 19.0% | 18.0% | 19.9% | 23.0% | 24.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.97 | 5.98 | 5.97 | 5.97 | 5.98 | 5.98 | 5.99 | 5.99 | 5.99 | 6.00 | 5.99 | 5.99 |
| Reserves | 68.80 | 84.76 | 200 | 240 | 305 | 332 | 374 | 479 | 581 | 668 | 740 | 762 |
| Borrowings | 77.32 | 64.21 | 88.29 | 204 | 144 | 116 | 111 | 138 | 146 | 124 | 94.35 | 60.22 |
| Other Liabilities | 76.84 | 55.04 | 93.35 | 116 | 144 | 135 | 110 | 144 | 156 | 170 | 162 | 182 |
| Total Liabilities | 229 | 209 | 386 | 566 | 600 | 590 | 600 | 765 | 888 | 967 | 1,002 | 1,009 |
| Fixed Assets | 92.39 | 94.26 | 117 | 180 | 237 | 288 | 288 | 296 | 366 | 399 | 362 | 344 |
| CWIP | 4.99 | 9.97 | 12.98 | 55.94 | 32.93 | 18.96 | 13.98 | 15.97 | 23.94 | 5.99 | 4.99 | 4.99 |
| Investments | 5.01 | 5.01 | 131 | 144 | 149 | 118 | 142 | 196 | 239 | 322 | 328 | 317 |
| Other Assets | 126 | 99.75 | 125 | 188 | 179 | 165 | 156 | 257 | 259 | 241 | 306 | 343 |
| Inventories | 26.99 | 38.04 | 37.01 | 45.99 | 56.06 | 50.01 | 37.01 | 66.02 | 64.97 | 64.01 | 67.03 | 50.04 |
| Trade receivables | 81.78 | 45.86 | 66.83 | 92.70 | 92.82 | 89.83 | 75.84 | 98.68 | 118 | 91.73 | 103 | 150 |
| Cash & equivalents | 2.01 | 4.01 | 1.01 | 2.01 | 1.01 | 1.01 | 22.07 | 51.18 | 25.08 | 31.09 | 101 | 115 |
| Total Assets | 229 | 209 | 386 | 566 | 600 | 590 | 600 | 765 | 888 | 967 | 1,002 | 1,009 |
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | 18.99 | 44.01 | 46.95 | 6.99 | 128 | 111 | 34.96 | 46.96 | 111 | 97.96 | 135 |
| Cash from investing activity | — | 14.05 | −16.06 | −31.11 | −103 | −45.18 | −33.13 | −17.07 | −70.25 | −13.04 | −32.14 | −30.12 |
| Cash from financing activity | — | −33.12 | −27.12 | −17.06 | 96.39 | −83.32 | −77.34 | −3.01 | 9.03 | −94.35 | −64.21 | −56.20 |
| Net cash flow | — | 0.00 | 1.01 | −1.01 | 0.00 | 0.00 | 0.00 | 15.01 | −14.03 | 4.01 | 3.01 | 48.05 |
| Capex | 11.19 | 9.34 | 17.19 | 37.01 | 120 | 47.95 | 37.47 | 17.58 | 47.87 | 49.43 | 39.73 | 20.91 |
| Free cash flow | — | 24.05 | 27.07 | 10.03 | −112 | 80.27 | 74.26 | 20.06 | 9.03 | 66.18 | 60.18 | 116 |
| CFO / OP % | — | 52.0% | 103.0% | 106.0% | 38.0% | 126.0% | 114.0% | 81.0% | 70.0% | 97.0% | 133.0% | 140.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 103 | 59 | 78 | 94 | 57 | 58 | 82 | 60 | 52 | 58 | 58 | 88 |
| Inventory days | 69 | 112 | 92 | 88 | 69 | 71 | 83 | 78 | 55 | 83 | 75 | 64 |
| Days payable | 114 | 60 | 83 | 103 | 72 | 73 | 81 | 65 | 45 | 58 | 70 | 87 |
| Cash conversion cycle | 58 | 111 | 86 | 79 | 55 | 55 | 84 | 73 | 62 | 82 | 62 | 65 |
| Working capital days | 11 | 22 | 10 | −8 | 11 | 60 | 27 | 17 | 32 | 44 | 44 | 52 |
| ROCE % | 22.0% | 28.0% | 23.0% | 13.0% | 27.0% | 24.0% | 7.0% | 18.0% | 20.0% | 9.0% | 10.0% | 8.0% |
For the Jun 2026 quarter, Transpek Industry reported sales of ₹150 Cr, down 2.1% year on year and net profit of ₹8.92 Cr, down 42.7% year on year. The operating margin was 13.4%.
Transpek Industry's sales for the year to Mar 2026 were ₹619 Cr; over the last twelve months they were ₹616 Cr.
Net profit for the year to Mar 2026 was ₹45.93 Cr, and ₹38.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹69.56.
Transpek Industry reported borrowings of ₹60.22 Cr at Mar 2026, against cash and equivalents of ₹115 Cr.
Cash from operations was ₹135 Cr in the year to Mar 2025; after capital spending, free cash flow was ₹116 Cr.